Medicover AB (publ)

Stockholm Stock Exchange MCOV-B.ST

Medicover AB (publ) Net Cash Used For Investing Activities for the year ending December 31, 2023: USD -132.23 M

Medicover AB (publ) Net Cash Used For Investing Activities is USD -132.23 M for the year ending December 31, 2023, a 33.12% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.

Medicover AB (publ) Net Cash Used For Investing Activities for the year ending December 31, 2022 was USD -197.72 M, a 47.93% change year over year.
Medicover AB (publ) Net Cash Used For Investing Activities for the year ending December 31, 2021 was USD -379.75 M, a -146.14% change year over year.
Medicover AB (publ) Net Cash Used For Investing Activities for the year ending December 31, 2020 was USD -154.28 M, a 3.05% change year over year.
Medicover AB (publ) Net Cash Used For Investing Activities for the year ending December 31, 2019 was USD -159.13 M, a -19.76% change year over year.

Key data

Date	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure

Stockholm Stock Exchange: MCOV-B.ST

Medicover AB (publ)

CEO	Mr. Fredrik Rågmark
IPO Date	May 23, 2017
Location	Sweden
Headquarters	P.O. Box 5283
Employees	45,000
Sector	Healthcare
Industries Biotechnology Dental Care Medical Instruments Personal Care Pharmaceuticals

Description

Medicover AB (publ) provides healthcare and diagnostic services in Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It operates through two segment, Healthcare Services and Diagnostic Services. The company's diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. The company operates 97 clinical laboratories, 733 blood-drawing points, and 26 clinics in 10 countries; and 117 medical clinics, 20 fertility clinics, 52 dental clinics, 25 hospitals, and 25 gyms. It serves corporate and private customers, and patients, as well as public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.

Key trends

Past 5 years